Abeona Therapeutics Inc vs Paycom Software Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Paycom Software Inc trades at $209.22 (market cap $9.57B). The key difference: Paycom Software Inc is far larger — about 22.7× Abeona Therapeutics Inc's market cap, and Paycom Software Inc pays a 0.71% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | PAYC | |
|---|---|---|
Market Cap | $421.19M | $9.57B |
Sector | Health | Technology |
52-Week High | $7.45 | $233.89 |
52-Week Low | $4.17 | $113.59 |
Enterprise Value | $276.10M | $10.35B |
Dividend Yield | — | 0.71% |
Trailing returns across standard periods
Latest headlines on both assets
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →